Phocas Financial’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,378
Closed -$2.01M – 110
2026
Q2
$2.01M Buy
+16,378
New +$1.71M 0.28% 115

Other funds holding PTGX

Phocas Financial's PTGX Position: Q3 2026 in Review

Phocas Financial sold out of Protagonist Therapeutics (PTGX) in Q3 2026, closing a stake of 16,378 shares — an estimated $2.01M sold.

Phocas Financial first reported a position in PTGX in Q2 2026 and held it in 1 quarter. The position peaked at $2.01M in Q2 2026. 379 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Phocas Financial reported no remaining Protagonist Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 16,378 Protagonist Therapeutics shares in Q3 2026, an estimated $2.01M.
  • Phocas Financial first reported a position in Protagonist Therapeutics in Q2 2026 and held it in 1 quarter.
  • Phocas Financial's Protagonist Therapeutics position peaked at $2.01M in Q2 2026.
  • 379 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.